Shuk L. Chau
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 2
- Oncology top 5%
- Viral-associated cancers and disorders 3
- Lung Cancer Research Studies 3
-
- Lung Cancer Treatments and Mutations 4
- Hepatology top 10%
- Pathology and Forensic Medicine top 10%
-
- RNA modifications and cancer 4
- TGF-β signaling in diseases 1
-
- interferon and immune responses 1
In The Last Decade
Shuk L. Chau
14 papers receiving 902 citations
Hit Papers
Peers
Comparison fields: 5 of 56
- Cancer Research 364
- Oncology 469
- Pulmonary and Respiratory Medicine 404
- Hepatology 85
- Pathology and Forensic Medicine 133
Countries citing papers authored by Shuk L. Chau
This map shows the geographic impact of Shuk L. Chau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuk L. Chau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuk L. Chau more than expected).
Fields of papers citing papers by Shuk L. Chau
This network shows the impact of papers produced by Shuk L. Chau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuk L. Chau. The network helps show where Shuk L. Chau may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shuk L. Chau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2020 | 29 | |
| 3 | 2020 | 10 | |
| 4 | 2020 | 10 | |
| 5 | 2020 | 17 | |
| 6 | 2019 | 28 | |
| 7 | 2018 | 36 | |
| 8 | 2017 | 42 | |
| 9 | MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non–Small Cell Lung Carcinoma with Poor Prognosisbreakdown → | 2016 | 330 |
| 10 | 2013 | 52 | |
| 11 | 2012 | 82 | |
| 12 | 2012 | 41 | |
| 13 | 2010 | 54 | |
| 14 | 2009 | 177 |
About Shuk L. Chau
Shuk L. Chau is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 14 papers that have together received 915 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers), Lung Cancer Treatments and Mutations (4 papers), Viral-associated cancers and disorders (3 papers), Lung Cancer Research Studies (3 papers), MicroRNA in disease regulation (2 papers), TGF-β signaling in diseases (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Cancer Research (364 citations), Oncology (469 citations) and Pulmonary and Respiratory Medicine (404 citations). Shuk L. Chau has collaborated with scholars based in Hong Kong, China and France. Frequent co-authors include Ka‐Fai To, Raymond Wai Ming Lung, Anthony W.H. Chan, Joanna H. Tong, Tony Mok, Chit Chow, Calvin S.H. Ng, Kwok Wai Lo, Joanna Hung‐Man Tong and Lau Y. Chung. Their work appears in journals such as PLoS ONE, Clinical Cancer Research and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.